Valeant, Exact Sciences & more — 4 GI company key notes

Here are four updates on GI companies from the past week:

Advertisement

Valeant reported net revenues of $2.21 billion in the third quarter of fiscal year 2017.

Exact Sciences is building a second laboratory facility in Madison, Wis., to meet growing demand for the company’s Cologuard test. The company also announced it would serve as the title sponsor of the Cologuard Classic, a PGA Tour Champions event in Tucson, Ariz.

Lumendi made its DiLumen Ig Endolumenal Interventional Grasper available in the U.S.

The last patient enrolled in Immuron’s IMM-124E phase II study completed their final visit. Results from the trial could be available as soon as the first quarter of 2018.

More articles on gastroenterology: 
GI leader to know: Dr. Thomas Ma of Penn State College
U of New Mexico to award Presidential Award of Distinction to Dr. Robert Strickland — 3 insights
Stock market week-in-review for 5 large GI companies — Nov. 6-10

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.